(b) FINDINGS.—Congress finds the following: 
(1) In the early morning hours of October 16, 
2002, the home of Carnell and Angela Dawson was 
firebombed 
in 
apparent 
retaliation 
for 
Mrs. 
Dawson’s notification of police about persistent drug 
distribution activity in their East Baltimore City 
neighborhood. 
(2) The arson claimed the lives of Mr. and Mrs. 
Dawson and their 5 young children, aged 9 to 14. 
(3) The horrific murder of the Dawson family 
is a stark example of domestic narco-terrorism. 
(4) In all phases of counter-narcotics law en-
forcement—from prevention to investigation to pros-
ecution to reentry—the voluntary cooperation of or-
dinary citizens is a critical component. 
(5) Voluntary cooperation is difficult for law en-
forcement officials to obtain when citizens feel that 
cooperation carries the risk of violent retaliation by 
illegal drug trafficking organizations and their affili-
ates. 
(6) Public confidence that law enforcement is 
doing all it can to make communities safe is a pre-
requisite for voluntary cooperation among people 
who may be subject to intimidation or reprisal (or 
both).
(7) Witness protection programs are insufficient 
on their own to provide security because many indi-
viduals and families who strive every day to make 
distressed neighborhoods livable for their children, 
other relatives, and neighbors will resist or refuse of-
fers of relocation by local, State, and Federal pros-
ecutorial agencies and because, moreover, the contin-
ued presence of strong individuals and families is 
critical to preserving and strengthening the social 
fabric in such communities. 
(8) Where (as in certain sections of Baltimore 
City) interstate trafficking of illegal drugs has severe 
ancillary local consequences within areas designated 
as high intensity drug trafficking areas, it is impor-
tant that supplementary High Intensity Drug Traf-
ficking Areas Program funds be committed to sup-
port initiatives aimed at making the affected com-
munities safe for the residents of those communities 
and encouraging their cooperation with local, State, 
and Federal law enforcement efforts to combat ille-
gal drug trafficking. 
(c) FUNDING FOR CERTAIN HIGH INTENSITY DRUG 
TRAFFICKING AREAS.—Section 707 (21 U.S.C. 1706), as 
amended by section 8, is further amended by adding at 
the end the following new subsection:
‘‘(o) SPECIFIC PURPOSES.—
‘‘(1) IN GENERAL.—The Director shall ensure 
that, of the amounts appropriated for a fiscal year 
for the Program, at least $5,000,000 is used in high 
intensity drug trafficking areas with severe neigh-
borhood safety and illegal drug distribution prob-
lems. 
‘‘(2) REQUIRED USES.—The funds used under 
paragraph (1) shall be used—
‘‘(A) to ensure the safety of neighborhoods 
and the protection of communities, including 
the prevention of the intimidation of potential 
witnesses of illegal drug distribution and related 
activities; and 
‘‘(B) to combat illegal drug trafficking 
through such methods as the Director considers 
appropriate, such as establishing or operating 
(or both) a toll-free telephone hotline for use by 
the public to provide information about illegal 
drug-related activities.’’. 
SEC. 10. AMENDMENTS RELATING TO COUNTER-DRUG 
TECHNOLOGY ASSESSMENT CENTER. 
(a) CHIEF SCIENTIST.—Section 708(b) (21 U.S.C. 
1707(b)) is amended—
(1) in the heading by striking ‘‘DIRECTOR OF 
TECHNOLOGY.—’’ 
and 
inserting 
‘‘CHIEF
SCI-
ENTIST.—’’; and 
(2) by striking ‘‘Director of Technology,’’ and 
inserting ‘‘Chief Scientist,’’. 
(b) ADDITIONAL RESPONSIBILITIES OF DIRECTOR.—
Section 708(c) (21 U.S.C. 1707(c)) is amended to read 
as follows: 
‘‘(c) ADDITIONAL RESPONSIBILITIES OF THE DIREC-
TOR OF NATIONAL DRUG CONTROL POLICY.—
‘‘(1) 
IN
GENERAL.—The 
Director, 
acting 
through the Chief Scientist shall—
‘‘(A) identify and define the short-, me-
dium-, and long-term scientific and techno-
logical needs of Federal, State, and local law 
enforcement agencies relating to drug enforce-
ment, including—
‘‘(i) advanced surveillance, tracking, 
and radar imaging; 
‘‘(ii) electronic support measures; 
‘‘(iii) communications; 
‘‘(iv) data fusion, advanced computer 
systems, and artificial intelligence; and
‘‘(v) chemical, biological, radiological 
(including neutron, electron, and graviton), 
and other means of detection; 
‘‘(B) identify demand reduction (including 
drug prevention) basic and applied research 
needs and initiatives, in consultation with af-
fected National Drug Control Program agen-
cies, including—
‘‘(i) improving treatment through 
neuroscientific advances; 
‘‘(ii) improving the transfer of bio-
medical research to the clinical setting; and 
‘‘(iii) in consultation with the Na-
tional Institute on Drug Abuse and the 
Substance Abuse and Mental Health Serv-
ices Administration, and through inter-
agency agreements or grants, examining 
addiction and rehabilitation research and 
the application of technology to expanding 
the effectiveness or availability of drug 
treatment; 
‘‘(C) make a priority ranking of such needs 
identified in subparagraphs (A) and (B) accord-
ing to fiscal and technological feasibility, as
part of a National Counterdrug Research and 
Development Program; 
‘‘(D) oversee and coordinate counterdrug 
technology initiatives with related activities of 
other Federal civilian and military departments; 
‘‘(E) provide support to the development 
and implementation of the national drug control 
performance measurement system established 
under subsection (b) of section 706; 
‘‘(F) with the advice and counsel of experts 
from State and local law enforcement agencies, 
oversee and coordinate a technology transfer 
program for the transfer of technology to State 
and local law enforcement agencies; and 
‘‘(G) pursuant to the authority of the Di-
rector of National Drug Control Policy under 
section 704, submit requests to Congress for 
the reprogramming or transfer of funds appro-
priated for counterdrug technology research and 
development. 
‘‘(2) PRIORITIES
IN
TRANSFERRING
TECH-
NOLOGY.—
‘‘(A) IN
GENERAL.—The Chief Scientist 
shall give priority, in transferring technology
under paragraph (1)(F), based on the following 
criteria: 
‘‘(i) the need of potential recipients 
for such technology; 
‘‘(ii) the effectiveness of the tech-
nology to enhance current counterdrug ac-
tivities of potential recipients; and 
‘‘(iii) the ability and willingness of po-
tential recipients to evaluate transferred 
technology. 
‘‘(B) INTERDICTION
AND
BORDER
DRUG 
LAW
ENFORCEMENT
TECHNOLOGIES.—The 
Chief Scientist shall give priority, in transfer-
ring technologies most likely to assist in drug 
interdiction and border drug law enforcement, 
to State, local, and tribal law enforcement agen-
cies in southwest border areas and northern 
border areas with significant traffic in illicit 
drugs. 
‘‘(3) LIMITATION ON AUTHORITY.—The author-
ity granted to the Director under this subsection 
shall not extend to the direct management of indi-
vidual projects or other operational activities. 
‘‘(4) REPORT.—On or before July 1 of each 
year, the Director shall submit a report to the ap-
propriate congressional committees that addresses 
the following: 
‘‘(A) The number of requests received dur-
ing the previous 12 months, including the iden-
tity of each requesting agency and the type of 
technology requested. 
‘‘(B) The number of requests fulfilled dur-
ing the previous 12 months, including the iden-
tity of each recipient agency and the type of 
technology transferred. 
‘‘(C) A summary of the criteria used in 
making the determination on what requests 
were funded and what requests were not fund-
ed, except that such summary shall not include 
specific information on any individual requests. 
‘‘(D) A general assessment of the future 
needs of the program, based on expected 
changes in threats, expected technologies, and 
likely need from potential recipients. 
‘‘(E) An assessment of the effectiveness of 
the technologies transferred, based in part on 
the evaluations provided by the recipients, with 
a recommendation whether the technology 
should continue to be offered through the pro-
gram.’’.
(c) ASSISTANCE FROM SECRETARY OF HOMELAND 
SECURITY.—Section 708(d) (21 U.S.C. 1707(d)) is 
amended by inserting ‘‘, the Secretary of Homeland Secu-
rity,’’ after ‘‘The Secretary of Defense’’. 
SEC. 11. NATIONAL YOUTH ANTIDRUG MEDIA CAMPAIGN. 
(a) IN GENERAL.—Section 709 (21 U.S.C. 1708) is 
amended to read as follows: 
‘‘SEC. 709. NATIONAL YOUTH ANTIDRUG MEDIA CAMPAIGN. 
‘‘(a) IN GENERAL.—The Director shall conduct a na-
tional youth anti-drug media campaign (referred to in this 
subtitle as the ‘national media campaign’) in accordance 
with this section for the purposes of—
‘‘(1) preventing drug abuse among young peo-
ple in the United States; 
‘‘(2) increasing awareness of adults of the im-
pact of drug abuse on young people; and 
‘‘(3) encouraging parents and other interested 
adults to discuss with young people the dangers of 
illegal drug use. 
‘‘(b) USE OF FUNDS.—
‘‘(1) IN GENERAL.—Amounts made available to 
carry out this section for the national media cam-
paign may only be used for the following:
‘‘(A) The purchase of media time and 
space, including the strategic planning for, and 
accounting of, such purchases. 
‘‘(B) Creative and talent costs, consistent 
with paragraph (2)(A). 
‘‘(C) Advertising production costs. 
‘‘(D) Testing and evaluation of advertising. 
‘‘(E) Evaluation of the effectiveness of the 
national media campaign. 
‘‘(F) The negotiated fees for the winning 
bidder on requests for proposals issued either 
by the Office or its designee to enter into con-
tracts to carry out activities authorized by this 
section. 
‘‘(G) Partnerships with professional and 
civic groups, community-based organizations, 
including faith-based organizations, and govern-
ment organizations related to the national 
media campaign. 
‘‘(H) Entertainment industry outreach, 
interactive outreach, media projects and activi-
ties, public information, news media outreach, 
and corporate sponsorship and participation. 
‘‘(I) Operational and management ex-
penses.
‘‘(2) SPECIFIC REQUIREMENTS.—
‘‘(A) CREATIVE SERVICES.—
‘‘(i) In using amounts for creative and 
talent costs under paragraph (1)(B), the 
Director shall use creative services donated 
at no cost to the Government (including 
creative services provided by the Partner-
ship for a Drug-Free America) wherever 
feasible and may only procure creative 
services for advertising—
‘‘(I) responding to high-priority 
or emergent campaign needs that can-
not timely be obtained at no cost; or 
‘‘(II) intended to reach a minor-
ity, ethnic, or other special audience 
that cannot reasonably be obtained at 
no cost; or 
‘‘(III) the Director determines 
that the Partnership for a Drug-Free 
America is unable to provide, pursu-
ant to subsection (d)(2)(B). 
‘‘(ii) No more than $1,500,000 may 
be expended under this section each fiscal 
year on creative services, except that the 
Director may expend up to $2,000,000 in
a fiscal year on creative services to meet 
urgent needs of the national media cam-
paign with advance approval from the 
Committee on Appropriations of the House 
of Representatives and of the Senate upon 
a showing of the circumstances causing 
such urgent needs of the national media 
campaign. 
‘‘(B) TESTING AND EVALUATION OF AD-
VERTISING.—In using amounts for testing and 
evaluation of advertising under paragraph 
(1)(D), the Director shall test all advertise-
ments prior to use in the national media cam-
paign to ensure that the advertisements are ef-
fective and meet industry-accepted standards. 
The Director may waive this requirement for 
advertisements using no more than 10 percent 
of the purchase of advertising time purchased 
under this section in a fiscal year and no more 
than 10 percent of the advertising space pur-
chased under this section in a fiscal year, if the 
advertisements respond to emergent and time-
sensitive campaign needs or the advertisements 
will not be widely utilized in the national media 
campaign.
‘‘(C) EVALUATION OF EFFECTIVENESS OF 
MEDIA CAMPAIGN.—In using amounts for the 
evaluation of the effectiveness of the national 
media campaign under paragraph (1)(E), the 
Director shall—
‘‘(i) designate an independent entity 
to evaluate annually the effectiveness of 
the national media campaign based on 
data from—
‘‘(I) the Monitoring the Future 
Study published by the Department of 
Health and Human Services; 
‘‘(II) 
the 
Attitude 
Tracking 
Study published by the Partnership 
for a Drug Free America; 
‘‘(III) the National Household 
Survey on Drug Abuse; and 
‘‘(IV) other relevant studies or 
publications, as determined by the Di-
rector, including tracking and evalua-
tion data collected according to mar-
keting and advertising industry stand-
ards; and 
‘‘(ii) ensure that the effectiveness of 
the national media campaign is evaluated
in a manner that enables consideration of 
whether the national media campaign has 
contributed to reduction of illicit drug use 
among youth and such other measures of 
evaluation as the Director determines are 
appropriate. 
‘‘(3) PURCHASE
OF
ADVERTISING
TIME
AND 
SPACE.—For each fiscal year, not less than 77 per-
cent of the amounts appropriated under this section 
shall be used for the purchase of advertising time 
and space for the national media campaign, subject 
to the following exceptions: 
‘‘(A) In any fiscal year for which less than 
$125,000,000 is appropriated for the national 
media campaign, not less than 82 percent of 
the amounts appropriated under this section 
shall be used for the purchase of advertising 
time and space for the national media cam-
paign. 
‘‘(B) In any fiscal year for which more 
than $195,000,000 is appropriated under this 
section, not less than 72 percent shall be used 
for advertising production costs and the pur-
chase of advertising time and space for the na-
tional media campaign.
‘‘(c) ADVERTISING.—In carrying out this section, the 
Director shall ensure that sufficient funds are allocated 
to meet the stated goals of the national media campaign. 
‘‘(d) DIVISION
OF RESPONSIBILITIES
AND FUNC-
TIONS UNDER THE PROGRAM.—
‘‘(1) IN GENERAL.—The Director, in consulta-
tion with the Partnership for a Drug-Free America, 
shall determine the overall purposes and strategy of 
the national media campaign. 
‘‘(2) RESPONSIBILITIES.—
‘‘(A) DIRECTOR.—The Director shall be 
responsible for implementing a focused national 
media campaign to meet the purposes set forth 
in subsection (a), and shall approve—
‘‘(i) the strategy of the national media 
campaign; 
‘‘(ii) all advertising and promotional 
material used in the national media cam-
paign; and 
‘‘(iii) the plan for the purchase of ad-
vertising time and space for the national 
media campaign. 
‘‘(B) THE
PARTNERSHIP
FOR
A
DRUG-
FREE
AMERICA.—The Director shall request
that the Partnership for a Drug-Free Amer-
ica—
‘‘(i) develop and recommend strategies 
to achieve the goals of the national media 
campaign, including addressing national 
and local drug threats in specific regions 
or States, such as methamphetamine and 
ecstasy; 
‘‘(ii) create all advertising to be used 
in the national media campaign, except ad-
vertisements that are—
‘‘(I) provided by other nonprofit 
entities pursuant to subsection (f); 
‘‘(II) intended to respond to 
high-priority or emergent campaign 
needs that cannot timely be obtained 
at no cost (not including production 
costs and talent reuse payments), pro-
vided that any such advertising mate-
rial is reviewed by the Partnership for 
a Drug-Free America; 
‘‘(III) intended to reach a minor-
ity, ethnic, or other special audience 
that cannot be obtained at no cost 
(not including production costs and
talent reuse payments), provided that 
any such advertising material is re-
viewed by the Partnership for a Drug-
Free America; or 
‘‘(IV) any other advertisements 
that the Director determines that the 
Partnership for a Drug-Free America 
is unable to provide. 
‘‘(C) MEDIA
BUYING
CONTRACTOR.—The 
Director shall enter into a contract with a 
media buying contractor to plan and purchase 
advertising time and space for the national 
media campaign. The media buying contractor 
shall not provide any other service or material, 
or conduct any other function or activity which 
the Director determines should be provided by 
the Partnership for a Drug-Free America. 
‘‘(e) PROHIBITIONS.—None of the amounts made 
available under subsection (b) may be obligated or ex-
pended for any of the following: 
‘‘(1) To supplant current antidrug community-
based coalitions. 
‘‘(2) To supplant pro bono public service time 
donated by national and local broadcasting networks 
for other public service campaigns.
‘‘(3) For partisan political purposes, or express 
advocacy in support of or to defeat any clearly iden-
tified candidate, clearly identified ballot initiative, or 
clearly identified legislative or regulatory proposal. 
‘‘(4) To fund advertising that features any 
elected officials, persons seeking elected office, cabi-
net level officials, or other Federal officials employed 
pursuant to section 213 of Schedule C of title 5, 
Code of Federal Regulations. 
‘‘(5) To fund advertising that does not contain 
a primary message intended to reduce or prevent il-
licit drug use. 
‘‘(6) To fund advertising containing a primary 
message intended to promote support for the media 
campaign or private sector contributions to the 
media campaign. 
‘‘(f) MATCHING REQUIREMENT.—
‘‘(1) IN
GENERAL.—Amounts made available 
under subsection (b) for media time and space shall 
be matched by an equal amount of non-Federal 
funds for the national media campaign, or be 
matched with in-kind contributions of the same 
value. 
‘‘(2) NO-COST MATCH ADVERTISING DIRECT RE-
LATIONSHIP REQUIREMENT.—The Director shall en-
sure that at least 70 percent of no-cost match adver-
tising provided directly relates to substance abuse 
prevention consistent with the specific purposes of 
the national media campaign, except that in any fis-
cal year in which less than $125,000,000 is appro-
priated to the national media campaign, the Director 
shall ensure that at least 85 percent of no-cost 
match advertising directly relates to substance abuse 
prevention consistent with the specific purposes of 
the national media campaign. 
‘‘(3) NO-COST
MATCH
ADVERTISING
NOT
DI-
RECTLY RELATED.—The Director shall ensure that 
no-cost match advertising that does not directly re-
late to substance abuse prevention consistent with 
the purposes of the national media campaign in-
cludes a clear antidrug message. Such message is 
not required to be the primary message of the match 
advertising. 
‘‘(4) SPONSORSHIP IDENTIFICATION.—Any ad-
vertising material donated to the national media 
campaign at no cost shall not be subject to the spon-
sorship identification provisions in section 317 of the 
Communications Act of 1934 (47 U.S.C. 317). 
‘‘(g) FINANCIAL
AND
PERFORMANCE
ACCOUNT-
ABILITY.—The Director shall cause to be performed—
‘‘(1) audits and reviews of costs of the national 
media campaign pursuant to section 304C of the 
Federal Property and Administrative Services Act of 
1949 (41 U.S.C. 254d); and 
‘‘(2) an audit to determine whether the costs of 
the national media campaign are allowable under 
section 306 of such Act (41 U.S.C. 256). 
‘‘(h) REPORT
TO CONGRESS.—The Director shall 
submit on an annual basis a report to Congress that de-
scribes—
‘‘(1) the strategy of the national media cam-
paign and whether specific objectives of the media 
campaign were accomplished; 
‘‘(2) steps taken to ensure that the national 
media campaign operates in an effective and effi-
cient manner consistent with the overall strategy 
and focus of the national media campaign; 
‘‘(3) plans to purchase advertising time and 
space; 
‘‘(4) policies and practices implemented to en-
sure that Federal funds are used responsibly to pur-
chase advertising time and space and eliminate the 
potential for waste, fraud, and abuse; and
‘‘(5) all contracts entered into with a corpora-
tion, partnership, or individual working on behalf of 
the national media campaign. 
‘‘(i) LOCAL TARGET REQUIREMENT.—The Director 
shall, to the maximum extent feasible, use amounts made 
available under this section for media that focuses on, or 
includes specific information on, prevention or treatment 
resources for consumers within specific local areas. 
‘‘(j) PREVENTION OF MARIJUANA USE.—
‘‘(1) FINDINGS.—The Congress finds the fol-
lowing: 
‘‘(A) 60 percent of adolescent admissions 
for drug treatment are based on marijuana use. 
‘‘(B) Potency levels of contemporary mari-
juana, particularly hydroponically grown mari-
juana, are significantly higher than in the past, 
rising from under 1 percent of THC in the mid-
1970s to as high as 30 percent today. 
‘‘(C) Contemporary research has dem-
onstrated that youths smoking marijuana early 
in life may be up to five times more likely to 
use hard drugs. 
‘‘(D) Contemporary research has dem-
onstrated clear detrimental effects in adolescent
educational achievement resulting from mari-
juana use. 
‘‘(E) Contemporary research has dem-
onstrated clear detrimental effects in adolescent 
brain development resulting from marijuana 
use. 
‘‘(F) An estimated 9,000,000 Americans a 
year drive while under the influence of illegal 
drugs, including marijuana. 
‘‘(G) Marijuana smoke contains 50 to 70 
percent more of certain cancer causing chemi-
cals than tobacco smoke. 
‘‘(H) Teens who use marijuana are up to 
four times more likely to have a teen pregnancy 
than teens who have not. 
‘‘(I) Federal law enforcement agencies 
have identified clear links suggesting that trade 
in hydroponic marijuana facilitates trade by 
criminal organizations in hard drugs, including 
heroin. 
‘‘(J) Federal law enforcement agencies 
have identified possible links between trade in 
cannabis products and financing for terrorist 
organizations.
‘‘(2) EMPHASIS
ON
PREVENTION
OF
YOUTH 
MARIJUANA USE.—In conducting advertising and ac-
tivities otherwise authorized under this section, the 
Director may emphasize prevention of youth mari-
juana use. 
‘‘(k) AUTHORIZATION OF APPROPRIATIONS.—There 
is authorized to be appropriated to the Office to carry out 
this section, $195,000,000 for each of fiscal years 2006 
and 2007 and $210,000,000 for each of fiscal years 2008 
through 2010.’’. 
(b) REPEAL
OF SUPERSEDED PROVISIONS.—The 
Drug-Free Media Campaign Act of 1998 (21 U.S.C. 1801 
et seq.) is repealed. 
SEC. 12. DRUG INTERDICTION. 
(a) IN GENERAL.—Section 711 (21 U.S.C. 1710) is 
amended to read as follows: 
‘‘(a) UNITED
STATES
INTERDICTION
COORDI-
NATOR.—
‘‘(1) IN GENERAL.—The Deputy Director for 
Supply Reduction in the Office shall serve as the 
United States Interdiction Coordinator, and shall 
perform the duties of that position described in 
paragraph (2) and such other duties as may be de-
termined by the Director with respect to coordina-
tion of efforts to interdict illicit drugs from the 
United States. 
‘‘(2) RESPONSIBILITIES.—The United States 
Interdiction Coordinator shall be responsible to the 
Director for 
‘‘(A) coordinating the interdiction activities 
of the National Drug Control Program agencies 
to ensure consistency with the National Drug 
Control Strategy; 
‘‘(B) developing and issuing, on or before 
March 1 of each year and in accordance with 
paragraph (3), a National Interdiction Com-
mand and Control Plan to ensure the coordina-
tion and consistency described in subparagraph 
(A); 
‘‘(C) assessing the sufficiency of assets 
committed to illicit drug interdiction by the rel-
evant National Drug Control Program agencies; 
and 
‘‘(D) advising the Director on the efforts 
of each National Drug Control Program agency 
to implement the National Interdiction Com-
mand and Control Plan. 
‘‘(3) NATIONAL INTERDICTION COMMAND AND 
CONTROL PLAN.—